Multidisciplinary management of brain Metastases

被引:259
作者
Eichler, April F.
Loeffler, Jay S.
机构
[1] Massachusetts Gen Hosp, Pappas Ctr Neurooncol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
关键词
neoplasm metastasis; brain neoplasms; therapeutics; ionizing radiation; drug therapy;
D O I
10.1634/theoncologist.12-7-884
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastatic brain tumors are the most common intracranial neoplasms in adults. The incidence of brain metastases appears to be rising as a result of superior imaging modalities, earlier detection, and more effective treatment of systemic disease. Therapeutic approaches to brain metastases include surgery, whole brain radiotherapy (WBRT), stereotactic radiosurgery (SRS), and chemotherapy. Treatment decisions must take into account clinical prognostic factors in order to maximize survival and neurologic function whilst avoiding unnecessary treatments. The goal of this article is to review important prognostic factors that may guide treatment selection, discuss the roles of surgery, radiation, and chemotherapy in the treatment of patients with brain metastases, and present new directions in brain metastasis therapy under active investigation. In the future, patients will benefit from a multidisciplinary approach focused on the integration of surgical, radiation, and chemotherapeutic options with the goal of prolonging survival, preserving neurologic and neurocognitive function, and maximizing quality of life.
引用
收藏
页码:884 / 898
页数:15
相关论文
共 138 条
[41]  
DEANGELIS LM, 1989, J NEURO-ONCOL, V7, P241
[42]   DISTRIBUTION OF BRAIN METASTASES [J].
DELATTRE, JY ;
KROL, G ;
THALER, HT ;
POSNER, JB .
ARCHIVES OF NEUROLOGY, 1988, 45 (07) :741-744
[43]   Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases: a phase II study of the EORTC Lung Cancer Group (08965) [J].
Dziadziuszko, R ;
Ardizzoni, A ;
Postmus, PE ;
Smit, EF ;
Price, A ;
Debruyne, C ;
Legrand, C ;
Giaccone, G .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (09) :1271-1276
[44]  
EWING J, 1940, NEOPLASTIC DIS TREAT, P62
[45]  
EYRE HJ, 1984, J NEURO-ONCOL, V2, P325
[46]   Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: Another arrow at the bow? [J].
Fabi, A ;
Vidiri, A ;
Ferretti, G ;
Felici, A ;
Papaldo, P ;
Carlini, P ;
Mirri, A ;
Nuzzo, C ;
Cognetti, F .
CANCER INVESTIGATION, 2006, 24 (04) :466-468
[47]   Determinants of outcome in melanoma patients with cerebral metastases [J].
Fife, KM ;
Colman, MH ;
Stevens, GN ;
Firth, IC ;
Moon, D ;
Shannon, KF ;
Harman, R ;
Petersen-Schaefer, K ;
Zacest, AC ;
Besser, M ;
Milton, GW ;
McCarthy, WH ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1293-1300
[48]   A MULTIINSTITUTIONAL EXPERIENCE WITH STEREOTAXIC RADIOSURGERY FOR SOLITARY BRAIN METASTASIS [J].
FLICKINGER, JC ;
KONDZIOLKA, D ;
LUNSFORD, LD ;
COFFEY, RJ ;
GOODMAN, ML ;
SHAW, EG ;
HUDGINS, WR ;
WEINER, R ;
HARSH, GR ;
SNEED, PK ;
LARSON, DA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (04) :797-802
[49]  
Franciosi V, 1999, CANCER, V85, P1599, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1599::AID-CNCR23>3.3.CO
[50]  
2-R